nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—Phase II conjugation—COMT—bipolar disorder	0.0164	0.0229	CbGpPWpGaD
Lorazepam—Amoxapine—DRD4—bipolar disorder	0.0163	0.0762	CrCbGaD
Lorazepam—GABRB3—Ion channel transport—TRPM2—bipolar disorder	0.0162	0.0226	CbGpPWpGaD
Lorazepam—GABRG2—Ion channel transport—TRPM2—bipolar disorder	0.0159	0.0222	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.0157	0.0218	CbGpPWpGaD
Lorazepam—Amoxapine—DRD3—bipolar disorder	0.0141	0.0657	CrCbGaD
Lorazepam—GABRA1—Ion channel transport—TRPM2—bipolar disorder	0.0139	0.0194	CbGpPWpGaD
Lorazepam—Amoxapine—DRD1—bipolar disorder	0.0138	0.0645	CrCbGaD
Lorazepam—Amoxapine—SLC6A3—bipolar disorder	0.0131	0.0611	CrCbGaD
Lorazepam—Chlorprothixene—DRD3—bipolar disorder	0.0126	0.0588	CrCbGaD
Lorazepam—Chlorprothixene—DRD1—bipolar disorder	0.0124	0.0577	CrCbGaD
Lorazepam—TSPO—blood plasma—bipolar disorder	0.0123	0.182	CbGeAlD
Lorazepam—Amoxapine—HTR2C—bipolar disorder	0.0118	0.0552	CrCbGaD
Lorazepam—Amoxapine—HTR1A—bipolar disorder	0.0115	0.0535	CrCbGaD
Lorazepam—GABRB3—GABA receptor activation—ADCY2—bipolar disorder	0.0114	0.0158	CbGpPWpGaD
Lorazepam—GABRG2—GABA receptor activation—ADCY2—bipolar disorder	0.0111	0.0155	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.0108	0.0151	CbGpPWpGaD
Lorazepam—Clozapine—DRD4—bipolar disorder	0.0107	0.05	CrCbGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.0106	0.0148	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2C—bipolar disorder	0.0106	0.0494	CrCbGaD
Lorazepam—Amoxapine—SLC6A4—bipolar disorder	0.00979	0.0457	CrCbGaD
Lorazepam—GABRA1—GABA receptor activation—ADCY2—bipolar disorder	0.00974	0.0136	CbGpPWpGaD
Lorazepam—Amoxapine—DRD2—bipolar disorder	0.00973	0.0455	CrCbGaD
Lorazepam—UGT2B15—Biological oxidations—COMT—bipolar disorder	0.00961	0.0134	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—MAOA—bipolar disorder	0.00954	0.0133	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.0093	0.0129	CbGpPWpGaD
Lorazepam—Clozapine—DRD3—bipolar disorder	0.00922	0.0431	CrCbGaD
Lorazepam—Clozapine—DRD1—bipolar disorder	0.00905	0.0423	CrCbGaD
Lorazepam—Chlorprothixene—DRD2—bipolar disorder	0.00871	0.0407	CrCbGaD
Lorazepam—GABRB3—Neuronal System—CPLX1—bipolar disorder	0.0083	0.0116	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—bipolar disorder	0.00828	0.0115	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—IMPA2—bipolar disorder	0.00822	0.0115	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CPLX1—bipolar disorder	0.00815	0.0113	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—bipolar disorder	0.00813	0.0113	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN1—bipolar disorder	0.0081	0.0113	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN1—bipolar disorder	0.00795	0.0111	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GRIN1—bipolar disorder	0.00792	0.011	CbGpPWpGaD
Lorazepam—Clozapine—HTR2C—bipolar disorder	0.00774	0.0362	CrCbGaD
Lorazepam—Amoxapine—HTR2A—bipolar disorder	0.00752	0.0351	CrCbGaD
Lorazepam—Clozapine—HTR1A—bipolar disorder	0.00752	0.0351	CrCbGaD
Lorazepam—GABRA1—Neuronal System—CPLX1—bipolar disorder	0.00712	0.00992	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—bipolar disorder	0.0071	0.00989	CbGpPWpGaD
Lorazepam—GABRB3—Ion channel transport—TRPC3—bipolar disorder	0.00706	0.00983	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN1—bipolar disorder	0.00695	0.00968	CbGpPWpGaD
Lorazepam—GABRG2—Ion channel transport—TRPC3—bipolar disorder	0.00693	0.00965	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2A—bipolar disorder	0.00673	0.0314	CrCbGaD
Lorazepam—Clozapine—DRD2—bipolar disorder	0.00638	0.0298	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.00637	0.00888	CbGpPWpGaD
Lorazepam—TSPO—adrenal cortex—bipolar disorder	0.00625	0.0922	CbGeAlD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.00622	0.00866	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—POMC—bipolar disorder	0.00621	0.00865	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.00611	0.00851	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.00609	0.00848	CbGpPWpGaD
Lorazepam—GABRA1—Ion channel transport—TRPC3—bipolar disorder	0.00606	0.00844	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.00598	0.00833	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00596	0.00831	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00586	0.00816	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.00581	0.00809	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.00581	0.00809	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00565	0.00786	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NTRK2—bipolar disorder	0.00561	0.00781	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—IMPA1—bipolar disorder	0.00556	0.00774	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.00555	0.00772	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00554	0.00772	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.00545	0.00758	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.00534	0.00744	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—bipolar disorder	0.00533	0.00743	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—bipolar disorder	0.00524	0.00729	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.00523	0.00728	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—bipolar disorder	0.00522	0.00727	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GRIN2B—bipolar disorder	0.00521	0.00726	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—bipolar disorder	0.00512	0.00714	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00512	0.00713	CbGpPWpGaD
Lorazepam—Clozapine—HTR2A—bipolar disorder	0.00493	0.023	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00485	0.00675	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00481	0.00669	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIK2—bipolar disorder	0.00477	0.00664	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.00476	0.00663	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00473	0.00659	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NDUFV2—bipolar disorder	0.00472	0.00658	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIK2—bipolar disorder	0.00468	0.00652	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIN1—bipolar disorder	0.00466	0.0065	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00464	0.00646	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00464	0.00646	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00464	0.00646	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIN1—bipolar disorder	0.00458	0.00638	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—bipolar disorder	0.00458	0.00637	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKR1C4—bipolar disorder	0.00457	0.00637	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NTRK1—bipolar disorder	0.00457	0.00637	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GAD1—bipolar disorder	0.00457	0.00636	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.00452	0.00629	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GAD1—bipolar disorder	0.00449	0.00625	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—bipolar disorder	0.00448	0.00624	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.00443	0.00617	CbGpPWpGaD
Lorazepam—TSPO—thyroid gland—bipolar disorder	0.00435	0.0642	CbGeAlD
Lorazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.00435	0.00606	CbGpPWpGaD
Lorazepam—GABRG2—nervous system—bipolar disorder	0.00433	0.0638	CbGeAlD
Lorazepam—GABRB3—Neuronal System—CACNB2—bipolar disorder	0.00425	0.00592	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—BDNF—bipolar disorder	0.00419	0.00583	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CACNB2—bipolar disorder	0.00417	0.00581	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NR1D1—bipolar disorder	0.00411	0.00572	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIK2—bipolar disorder	0.00409	0.0057	CbGpPWpGaD
Lorazepam—GABRG2—cerebellum—bipolar disorder	0.00407	0.0601	CbGeAlD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00401	0.00558	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIN1—bipolar disorder	0.004	0.00558	CbGpPWpGaD
Lorazepam—GABRB3—thyroid gland—bipolar disorder	0.00395	0.0583	CbGeAlD
Lorazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.00395	0.0055	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00394	0.00548	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCAN—bipolar disorder	0.00393	0.00547	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00392	0.00546	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GAD1—bipolar disorder	0.00392	0.00546	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.00388	0.0054	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00385	0.00537	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC5A3—bipolar disorder	0.00385	0.00536	CbGpPWpGaD
Lorazepam—GABRA1—nervous system—bipolar disorder	0.00382	0.0564	CbGeAlD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.0038	0.0053	CbGpPWpGaD
Lorazepam—TSPO—nervous system—bipolar disorder	0.00366	0.054	CbGeAlD
Lorazepam—GABRA1—Neuronal System—CACNB2—bipolar disorder	0.00365	0.00508	CbGpPWpGaD
Lorazepam—GABRA1—cerebellum—bipolar disorder	0.0036	0.053	CbGeAlD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00349	0.00486	CbGpPWpGaD
Lorazepam—TSPO—cerebellum—bipolar disorder	0.00345	0.0508	CbGeAlD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00344	0.00479	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SNAP25—bipolar disorder	0.0034	0.00473	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.00339	0.00472	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00337	0.00469	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00337	0.00469	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00336	0.00468	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00334	0.00465	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—SNAP25—bipolar disorder	0.00334	0.00464	CbGpPWpGaD
Lorazepam—GABRB3—nervous system—bipolar disorder	0.00332	0.049	CbGeAlD
Lorazepam—GABRG2—brain—bipolar disorder	0.00331	0.0488	CbGeAlD
Lorazepam—GABRG2—Transmission across Chemical Synapses—COMT—bipolar disorder	0.0033	0.00459	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00328	0.00456	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00324	0.00452	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00318	0.00443	CbGpPWpGaD
Lorazepam—GABRB3—cerebellum—bipolar disorder	0.00313	0.0461	CbGeAlD
Lorazepam—GABRB3—Neuronal System—GRIN2B—bipolar disorder	0.00307	0.00428	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SLC6A3—bipolar disorder	0.00303	0.00422	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIN2B—bipolar disorder	0.00302	0.0042	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—ADCY2—bipolar disorder	0.00301	0.00419	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00298	0.00415	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—SLC6A3—bipolar disorder	0.00297	0.00414	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—ADCY2—bipolar disorder	0.00295	0.00411	CbGpPWpGaD
Lorazepam—GABRA1—brain—bipolar disorder	0.00292	0.0431	CbGeAlD
Lorazepam—GABRA1—Neuronal System—SNAP25—bipolar disorder	0.00292	0.00406	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00288	0.00402	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00286	0.00399	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GSK3B—bipolar disorder	0.00285	0.00397	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00285	0.00397	CbGpPWpGaD
Lorazepam—TSPO—brain—bipolar disorder	0.0028	0.0413	CbGeAlD
Lorazepam—UGT2B15—Metabolism—CLOCK—bipolar disorder	0.00278	0.00388	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00278	0.00388	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TSHB—bipolar disorder	0.00271	0.00378	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CACNB2—bipolar disorder	0.00271	0.00378	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TPH2—bipolar disorder	0.00271	0.00378	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DPYD—bipolar disorder	0.00267	0.00372	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIN2B—bipolar disorder	0.00264	0.00367	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—SLC6A3—bipolar disorder	0.0026	0.00362	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—ADCY2—bipolar disorder	0.00258	0.00359	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—COMT—bipolar disorder	0.00257	0.00358	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MAOA—bipolar disorder	0.00256	0.00356	CbGpPWpGaD
Lorazepam—GABRB3—brain—bipolar disorder	0.00254	0.0375	CbGeAlD
Lorazepam—GABRG2—Neuronal System—COMT—bipolar disorder	0.00253	0.00352	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MAOA—bipolar disorder	0.00251	0.0035	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CACNA1C—bipolar disorder	0.00248	0.00346	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00246	0.00342	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3C2A—bipolar disorder	0.00242	0.00337	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00241	0.00336	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—COMT—bipolar disorder	0.00221	0.00308	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MAOA—bipolar disorder	0.00219	0.00306	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SNAP25—bipolar disorder	0.00217	0.00302	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00211	0.00294	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ADCY2—bipolar disorder	0.00192	0.00267	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00169	0.00235	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COMT—bipolar disorder	0.00164	0.00229	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MAOA—bipolar disorder	0.00163	0.00227	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00163	0.00227	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00162	0.00225	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.0016	0.00223	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00159	0.00221	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.0014	0.00195	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00139	0.00193	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—bipolar disorder	0.00133	0.00185	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—POMC—bipolar disorder	0.00106	0.00148	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—INS—bipolar disorder	0.00106	0.00147	CbGpPWpGaD
